...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Diabetes Science and Technology >Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long-Acting versus Short-Acting Insulins?
【24h】

Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long-Acting versus Short-Acting Insulins?

机译：胰岛素笔的不同体色和标签是否增强了患者正确识别注射长效胰岛素和短效胰岛素的笔的能力？

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: The objective of this study was to characterize how successfully patients with diabetes are able to distinguish between pens of the same pen type containing long- and short-acting insulins. Methods: Structured one-on-one interviews were conducted with 400 patients with diabetes in the United States, using either a differentiated ( n = 100) or undifferentiated ( n = 100) SoloSTAR? (insulin glargine vs insulin glulisine) or ( n = 200) FlexPen? (insulin detemir vs insulin aspart). A pair of each pen type was presented simultaneously, and participants were asked to identify the pen that they would use to (1) inject at lunch, (2) inject once daily, and (3) inject at breakfast and how they differentiated between pens. The short-acting insulin pen was then presented, and the interviewer asked whether this was the correct pen to administer insulin once or thrice daily. Results: More patients successfully identified the correct SoloSTAR pen across the tests vs FlexPen, and the error rate (incorrect selection/inability to select) was Significantly lower, respectively [2.7% ( n = 8) vs 16.3% ( n = 98)]. The most common reason cited for correct responses among all patients was color (of the label/pen, according to pen type). Conclusions: This study suggests that the full pen body color used on SoloSTAR pens enhances the patient's ability to differentiate between the pens for long- and short-acting insulin and is a notable improvement compared with the standard approach of differing label color.
机译：背景：本研究的目的是描述糖尿病患者如何成功地区分包含长效和短效胰岛素的同种笔。方法：在美国对400位糖尿病患者进行了结构化的一对一访谈，使用的是差异（n = 100）或未差异（n = 100）的SoloSTAR？ （甘精胰岛素与甘精胰岛素）或（n = 200）FlexPen？ （胰岛素德米尔与门冬胰岛素）。同时展示了每种笔的一对，并要求参与者确定他们将要使用的笔（1）在午餐时注射，（2）每天注射一次，（3）在早餐时注射以及他们如何区分这些笔。然后介绍了一种短效胰岛素笔，面试官问这是否是一次或每天三次注射胰岛素的正确笔。结果：与FlexPen相比，更多的患者成功地通过了测试确定了正确的SoloSTAR笔，错误率（错误选择/无法选择）分别显着降低了[2.7％（n = 8）对16.3％（n = 98）]。 。在所有患者中，导致正确反应的最常见原因是颜色（标签/笔的颜色，根据笔的类型）。结论：这项研究表明，SoloSTAR笔上使用的笔全色增强了患者区分长效和短效胰岛素的笔的能力，并且与不同标签颜色的标准方法相比有显着改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号